PM6

9H-purine-6-thiol

Created:2007-12-01
Last modified:  2020-06-05
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count14
Chiral Atom Count0
Bond Count15
Aromatic Bond Count10
2D diagram of PM6
Chemical Component Summary
Name9H-purine-6-thiol
Synonyms6-Mercaptopurine
Systematic Name (OpenEye OEToolkits)9H-purine-6-thiol
FormulaC5 H4 N4 S
Molecular Weight152.177
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESACDLabs10.04n2c1c(ncn1)c(nc2)S
SMILESCACTVS3.341Sc1ncnc2[nH]cnc12
SMILESOpenEye OEToolkits1.5.0c1[nH]c2c(n1)c(ncn2)S
Canonical SMILESCACTVS3.341 Sc1ncnc2[nH]cnc12
Canonical SMILESOpenEye OEToolkits1.5.0 c1[nH]c2c(n1)c(ncn2)S
InChIInChI1.03 InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)
InChIKeyInChI1.03 GLVAUDGFNGKCSF-UHFFFAOYSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB01033 
NameMercaptopurine
Groups
  • approved
  • investigational
DescriptionAn antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
Synonyms
  • 6 MP
  • 6-MP
  • Mercaptopurine
  • Mercaptopurine anhydrous
  • 6-Mercaptopurine
Brand Names
  • Purinethol
  • Xaluprine
  • Mercaptopurine
  • Purixan
  • Mercaptopurine Tablets USP
IndicationFor remission induction and maintenance therapy of acute lymphatic leukemia.
Categories
  • Antimetabolites
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Cytotoxins
  • Drugs for Obstructive Airway Diseases
ATC-Code
  • L01BB02
  • R03DA20
CAS number50-44-2

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Hypoxanthine-guanine phosphoribosyltransferaseMATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLA...unknowninhibitor
Inosine-5'-monophosphate dehydrogenase 1MADYLISGGTGYVPEDGLTAQQLFASADGLTYNDFLILPGFIDFIADEVD...unknowninhibitor
AmidophosphoribosyltransferaseMELEELGIREECGVFGCIASGEWPTQLDVPHVITLGLVGLQHRGQESAGI...unknowninhibitor
Inosine-5'-monophosphate dehydrogenaseMADYLISGGTGYVPEDGLTAQQLFASADGLTYNDFLILPGFIDFIADEVD...unknowninhibitor
Aldehyde oxidaseMDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCG...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1425
PubChem 4071, 667490
ChEMBL CHEMBL1425
ChEBI CHEBI:2208, CHEBI:50667, CHEBI:94796
CCDC/CSD QECHOV03, MERPUM04, QECHOV01, MERPUM03, EJEVIA, QECHOV02, QECHOV, GEQROL, RAKSIG, GEQRIF, UPABEV